| Braver et al., 2023 [16] | CAD | mHealth-integrated disease management programs | Usual care or non-digital programs | 18 studies; N = 1,009-1,514 | All-cause readmission: RR 0.68 (0.50-0.91); cardiac readmission: RR 0.55 (0.44-0.68); ED visit: RR 0.37 (0.26-0.54); mortality/MACE: NS |
| Ansari et al., 2025 [17] | CAD | Digital cardiac rehabilitation | Traditional center-based cardiac rehabilitation | 13 studies; N = 1,850 | QoL: Mean deviation 0.10 (0.05-0.15); rehospitalization: RR 0.86 (0.66-1.11); MACE RR: 0.67 (0.42-1.07) |
| Zhou et al., 2024 [18] | CVD | Smartphone-assisted cardiac rehabilitation | Usual care or conventional CR | 14 RCTs; N = 1,962 | VO2peak: WMD 1.32 (0.82-1.81); adherence: RR 1.62 (1.21-2.17); other outcomes: NS |
| Xu et al., 2019 [22] | CR participants | Mobile application–based CR support | Standard CR or usual care | 4 RCTs; N = 185 | CR completion/adherence: RR 1.38 (1.16-1.65); functional and QoL outcomes” mixed |
| Yu et al., 2023 [19] | CR participants | eHealth interventions (wearables, web, apps) | Usual care or no digital intervention | 18 studies | MVPA: SMD 0.18 (0.07-0.28); cardiovascular outcomes NS |
| Luijk et al., 2024 [20] | Post-CR patients | Digital interventions for PA maintenance | Usual care / no structured maintenance | 20 RCTs; N = 1,801 | Objective PA: NS; subjective PA: SMD 0.37 (0.05-0.69) |
| Chong et al., 2021 [21] | CAD/CVD | Technology-assisted CR | Conventional center-based CR | 9 RCTs | Risk factors and psychological outcomes: comparable between technology-assisted CR and CBCR |
| Popovici et al., 2023 [23] | CVD | Smartphones and digital methods in CR | Conventional CR or usual care | 7 studies; N = 802 | VO2peak and 6MWT favored intervention |
| Kenny et al., 2024 [24] | CVD | Digital CR incorporating behavior change techniques (BCT) | Varied / usual care | 25 RCTs | Digital CR demonstrated significant improvements in daily step counts, light-intensity physical activity, medication adherence, functional capacity, and LDL-cholesterol compared with usual care, while showing clinical effects largely comparable to those of CBCR. |